Global Neurological Disorder Drugs Market Research Report 2021
Global Neurological Disorder Drugs Market Research Report 2021
The Neurological Disorder Drugs Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Research Predicts that Neurological Disorder Drugs Market was valued USD xxxx unit in 2020 and is expected to reach USD xxxx Unit by the year 2025, growing at a CAGR of xx% globally.
Global Neurological Disorder Drugs Market Overview:
Global Neurological Disorder Drugs Market Report 2020 comes with the extensive industry analysis of development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2020-2025.This research study of Neurological Disorder Drugs involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Impact of COVID-19 on Neurological Disorder Drugs Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affected the Neurological Disorder Drugs market in 2020.
Global Neurological Disorder Drugs Market Segmentation
By Type, Neurological Disorder Drugs market has been segmented into:
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others
By Application, Neurological Disorder Drugs market has been segmented into:
Hospital
Clinic
Home
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Top Key Players Covered in Neurological Disorder Drugs market are:
Novartis AG
GlaxoSmithKline plc
Merck & Co.
Bayer AG
AstraZeneca
Boehringer Ingelheim GmbH
Teva Pharmaceutical Industries Ltd
1. Market Overview of Neurological Disorder Drugs
1.1 Neurological Disorder Drugs Market Overview
1.1.1 Neurological Disorder Drugs Product Scope
1.1.2 Market Status and Outlook
1.2 Neurological Disorder Drugs Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Neurological Disorder Drugs Historic Market Size by Regions (2015-2020)
1.4 Neurological Disorder Drugs Forecasted Market Size by Regions (2021-2026)
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth (2015-2026)
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Neurological Disorder Drugs Sales Market by Type (2015-2026)
2.1 Global Neurological Disorder Drugs Historic Market Size by Type (2015-2020)
2.2 Global Neurological Disorder Drugs Forecasted Market Size by Type (2021-2026)
2.3 Antipsychotic
2.4 Hypnotic & Sedative
2.5 Analgesics
2.6 Anticoagulants
2.7 Others
3. Covid-19 Impact Neurological Disorder Drugs Sales Market by Application (2015-2026)
3.1 Global Neurological Disorder Drugs Historic Market Size by Application (2015-2020)
3.2 Global Neurological Disorder Drugs Forecasted Market Size by Application (2021-2026)
3.3 Hospital
3.4 Clinic
3.5 Home
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Neurological Disorder Drugs Production Capacity Market Share by Manufacturers (2015-2020)
4.2 Global Neurological Disorder Drugs Revenue Market Share by Manufacturers (2015-2020)
4.3 Global Neurological Disorder Drugs Average Price by Manufacturers (2015-2020)
5. Company Profiles and Key Figures in Neurological Disorder Drugs Business
5.1 Novartis AG
5.1.1 Novartis AG Company Profile
5.1.2 Novartis AG Neurological Disorder Drugs Product Specification
5.1.3 Novartis AG Neurological Disorder Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.2 GlaxoSmithKline plc
5.2.1 GlaxoSmithKline plc Company Profile
5.2.2 GlaxoSmithKline plc Neurological Disorder Drugs Product Specification
5.2.3 GlaxoSmithKline plc Neurological Disorder Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.3 Merck & Co.
5.3.1 Merck & Co. Company Profile
5.3.2 Merck & Co. Neurological Disorder Drugs Product Specification
5.3.3 Merck & Co. Neurological Disorder Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.4 Bayer AG
5.4.1 Bayer AG Company Profile
5.4.2 Bayer AG Neurological Disorder Drugs Product Specification
5.4.3 Bayer AG Neurological Disorder Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.5 AstraZeneca
5.5.1 AstraZeneca Company Profile
5.5.2 AstraZeneca Neurological Disorder Drugs Product Specification
5.5.3 AstraZeneca Neurological Disorder Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.6 Boehringer Ingelheim GmbH
5.6.1 Boehringer Ingelheim GmbH Company Profile
5.6.2 Boehringer Ingelheim GmbH Neurological Disorder Drugs Product Specification
5.6.3 Boehringer Ingelheim GmbH Neurological Disorder Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
5.7 Teva Pharmaceutical Industries Ltd
5.7.1 Teva Pharmaceutical Industries Ltd Company Profile
5.7.2 Teva Pharmaceutical Industries Ltd Neurological Disorder Drugs Product Specification
5.7.3 Teva Pharmaceutical Industries Ltd Neurological Disorder Drugs Production Capacity, Revenue, Price and Gross Margin (2015-2020)
6. North America
6.1 North America Neurological Disorder Drugs Market Size (2015-2026)
6.2 North America Neurological Disorder Drugs Key Players in North America (2015-2020)
6.3 North America Neurological Disorder Drugs Market Size by Type (2015-2020)
6.4 North America Neurological Disorder Drugs Market Size by Application (2015-2020)
7. East Asia
7.1 East Asia Neurological Disorder Drugs Market Size (2015-2026)
7.2 East Asia Neurological Disorder Drugs Key Players in North America (2015-2020)
7.3 East Asia Neurological Disorder Drugs Market Size by Type (2015-2020)
7.4 East Asia Neurological Disorder Drugs Market Size by Application (2015-2020)
8. Europe
8.1 Europe Neurological Disorder Drugs Market Size (2015-2026)
8.2 Europe Neurological Disorder Drugs Key Players in North America (2015-2020)
8.3 Europe Neurological Disorder Drugs Market Size by Type (2015-2020)
8.4 Europe Neurological Disorder Drugs Market Size by Application (2015-2020)
9. South Asia
9.1 South Asia Neurological Disorder Drugs Market Size (2015-2026)
9.2 South Asia Neurological Disorder Drugs Key Players in North America (2015-2020)
9.3 South Asia Neurological Disorder Drugs Market Size by Type (2015-2020)
9.4 South Asia Neurological Disorder Drugs Market Size by Application (2015-2020)
10. Southeast Asia
10.1 Southeast Asia Neurological Disorder Drugs Market Size (2015-2026)
10.2 Southeast Asia Neurological Disorder Drugs Key Players in North America (2015-2020)
10.3 Southeast Asia Neurological Disorder Drugs Market Size by Type (2015-2020)
10.4 Southeast Asia Neurological Disorder Drugs Market Size by Application (2015-2020)
11. Middle East
11.1 Middle East Neurological Disorder Drugs Market Size (2015-2026)
11.2 Middle East Neurological Disorder Drugs Key Players in North America (2015-2020)
11.3 Middle East Neurological Disorder Drugs Market Size by Type (2015-2020)
11.4 Middle East Neurological Disorder Drugs Market Size by Application (2015-2020)
12. Africa
12.1 Africa Neurological Disorder Drugs Market Size (2015-2026)
12.2 Africa Neurological Disorder Drugs Key Players in North America (2015-2020)
12.3 Africa Neurological Disorder Drugs Market Size by Type (2015-2020)
12.4 Africa Neurological Disorder Drugs Market Size by Application (2015-2020)
13. Oceania
13.1 Oceania Neurological Disorder Drugs Market Size (2015-2026)
13.2 Oceania Neurological Disorder Drugs Key Players in North America (2015-2020)
13.3 Oceania Neurological Disorder Drugs Market Size by Type (2015-2020)
13.4 Oceania Neurological Disorder Drugs Market Size by Application (2015-2020)
14. South America
14.1 South America Neurological Disorder Drugs Market Size (2015-2026)
14.2 South America Neurological Disorder Drugs Key Players in North America (2015-2020)
14.3 South America Neurological Disorder Drugs Market Size by Type (2015-2020)
14.4 South America Neurological Disorder Drugs Market Size by Application (2015-2020)
15. Rest of the World
15.1 Rest of the World Neurological Disorder Drugs Market Size (2015-2026)
15.2 Rest of the World Neurological Disorder Drugs Key Players in North America (2015-2020)
15.3 Rest of the World Neurological Disorder Drugs Market Size by Type (2015-2020)
15.4 Rest of the World Neurological Disorder Drugs Market Size by Application (2015-2020)
16 Neurological Disorder Drugs Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter’s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
18.1 Research Methodology
18.1.1 Methodology/Research Approach
18.1.2 Data Source
18.2 Disclaimer
Research Methodology:
Neurological Disorder Drugs Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|